Georgia Leonie Barnes, FNP-C, PMHNP-BC
Psychiatric/Mental Health · Beverly Hills
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Georgia Leonie Barnes’s office at (310) 360-7600 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 53 Part D prescriptions in 2023.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 53 | 14 | 0% (0) | 0% | $1,940 |
| 2022 | 52 | None | 0% (0) | 0% | $2,319 |
| 2021 | 45 | None | 0% (0) | 0% | $678 |
| 2020 | 40 | 18 | 0% (0) | None | $2,513 |
| 2019 | 46 | None | 0% (0) | None | $10,890 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Duloxetine | 12 | $356 | $30 |
2022: 2 drugs
| Duloxetine | 15 | $1,555 | $104 |
| Mirtazapine | 14 | $38 | $3 |
2021: 1 drug
| Bupropion Xl | 12 | $150 | $13 |
Money from drug and device companies
$1,308 in 2025
| 2025 | 6 | 20 | None | $1,308 |
| 2024 | 5 | 14 | None | $533 |
| 2023 | 10 | 46 | None | $1,262 |
| 2022 | 14 | 41 | None | $1,393 |
| 2021 | 10 | 62 | None | $1,513 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Uzedy | $368 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $268 | 2 payments
|
| Abbvie | Vraylar | $264 | 11 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $263 | 2 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $116 | 1 payment
|
| Boston Scientific | General - Pain Management | $29 | 1 payment
|
See all 20 published payments
| Teva Pharmaceuticals USA | Meals · 2025-12-03 | Uzedy | $119 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-13 | Caplyta | $115 |
| Janssen Pharmaceuticals | Meals · 2025-10-28 | Invega Sustenna | $116 |
| Otsuka America Pharmaceutical | Meals · 2025-09-04 | Rexulti | $125 |
| Teva Pharmaceuticals USA | Meals · 2025-08-26 | Uzedy | $130 |
| Abbvie | Meals · 2025-08-19 | Vraylar | $18 |
| Abbvie | Meals · 2025-07-24 | Vraylar | $9 |
| Abbvie | Meals · 2025-07-15 | Vraylar | $28 |
| Abbvie | Meals · 2025-07-15 | Vraylar | $12 |
| Teva Pharmaceuticals USA | Meals · 2025-04-29 | Austedo Xr | $119 |
| Abbvie | Meals · 2025-04-24 | Vraylar | $23 |
| Abbvie | Meals · 2025-02-26 | Vraylar | $28 |
| Boston Scientific | Meals · 2025-02-25 | General - Pain Management | $29 |
| Abbvie | Meals · 2025-02-21 | Vraylar | $28 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-12 | Caplyta | $148 |
| Abbvie | Meals · 2025-02-06 | Vraylar | $32 |
| Abbvie | Meals · 2025-01-31 | Vraylar | $35 |
| Abbvie | Meals · 2025-01-11 | Vraylar | $26 |
| Abbvie | Meals · 2025-01-09 | Vraylar | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-01-07 | None | $143 |
See earlier years (2024, 2023, 2022, 2021)
2024: $533
| Abbvie | Vraylar | $161 | 10 payments
|
| Otsuka America Pharmaceutical | None | $123 | 1 payment
|
| Teva Pharmaceuticals USA | Uzedy | $123 | 1 payment
|
| Alkermes | Lybalvi | $102 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $24 | 1 payment
|
2023: $1,262
| Abbvie | Vraylar | $626 | 23 payments
|
| Lundbeck | Rexulti | $161 | 5 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $152 | 6 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $93 | 3 payments
|
| Alkermes | Aristada | $78 | 3 payments
|
| Teva Pharmaceuticals USA | Uzedy | $48 | 2 payments
|
| Indivior | Perseris | $28 | 1 payment
|
| Iti | Caplyta | $27 | 1 payment
|
| Neuronetics | Neurostar Tms Therapy System | $26 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $22 | 1 payment
|
2022: $1,393
| Iti | Caplyta | $462 | 7 payments
|
| Abbvie | Vraylar | $247 | 12 payments
|
| Janssen Pharmaceuticals | Spravato | $219 | 5 payments
|
| Almatica Pharma | Citalopram | $100 | 4 payments
|
| Alkermes | Lybalvi | $80 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Mycite | $70 | 3 payments
|
| Supernus Pharmaceuticals | Qelbree | $37 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $36 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $34 | 1 payment
|
| Vanda Pharmaceuticals | Hetlioz | $26 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $23 | 1 payment
|
| Merck Sharp & Dohme | Pifeltro | $22 | 1 payment
|
| OWP Pharmaceuticals | Subvenite | $20 | 1 payment
|
| Indivior | Perseris | $18 | 1 payment
|
2021: $1,513
| AbbVie | Vraylar | $824 | 34 payments
|
| Janssen Pharmaceuticals | Spravato | $247 | 8 payments
|
| Iti | Caplyta | $152 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $93 | 5 payments
|
| Orexo US | Zubsolv | $61 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $51 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $25 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $24 | 1 payment
|
| Bausch Health US | Wellbutrin | $23 | 1 payment
|
| Jazz Pharmaceuticals | Sunosi | $15 | 1 payment
|
Professional record
- NPI
- 1740642719
- Licence
- CA 95001120
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Nurse practitioner (363L00000X)
- Mailing address
- 8484 Wilshire Blvd Ste 200, Beverly Hills, CA, 90211
- NPI first listed
- 2016-03-28
- NPI last updated
- 2020-01-29
- NPI record certified
- 2020-01-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1200 Wilshire Blvd Ste 300, Los Angeles, CA, 90017 · 4211 Avalon Blvd, Los Angeles, CA, 90011 · 3701 Stocker St Ste 402, View Park, CA, 90008